GeneFerm Biotechnology Co., Ltd. (1796.TWO)

TWD 47.1

(-1.26%)

Net Debt Summary of GeneFerm Biotechnology Co., Ltd.

  • GeneFerm Biotechnology Co., Ltd.'s latest annual net debt in 2023 was 31.92 Million TWD , down -73.05% from previous year.
  • GeneFerm Biotechnology Co., Ltd.'s latest quarterly net debt in 2024 Q2 was 27.75 Million TWD , up 19.81% from previous quarter.
  • GeneFerm Biotechnology Co., Ltd. reported annual net debt of 118.46 Million TWD in 2022, up 258.15% from previous year.
  • GeneFerm Biotechnology Co., Ltd. reported annual net debt of -74.91 Million TWD in 2021, down -145.78% from previous year.
  • GeneFerm Biotechnology Co., Ltd. reported quarterly net debt of 23.16 Million TWD for 2024 Q1, down -27.44% from previous quarter.
  • GeneFerm Biotechnology Co., Ltd. reported quarterly net debt of 31.92 Million TWD for 2023 Q4, down -71.48% from previous quarter.

Annual Net Debt Chart of GeneFerm Biotechnology Co., Ltd. (2023 - 2019)

Historical Annual Net Debt of GeneFerm Biotechnology Co., Ltd. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 31.92 Million TWD -73.05%
2022 118.46 Million TWD 258.15%
2021 -74.91 Million TWD -145.78%
2020 163.65 Million TWD -69.06%
2019 528.92 Million TWD 0.0%

Peer Net Debt Comparison of GeneFerm Biotechnology Co., Ltd.

Name Net Debt Net Debt Difference
Allied Biotech Corporation 178.11 Million TWD 82.075%
Easywell Biomedicals, Inc. 123.43 Million TWD 74.136%
TTY Biopharm Company Limited -705.97 Million TWD 104.522%
Synmosa Biopharma Corporation 1.52 Billion TWD 97.901%
Orient EuroPharma Co., Ltd. 3.1 Billion TWD 98.972%
Center Laboratories, Inc. 3.91 Billion TWD 99.185%
Tien Liang BioTech Co., Ltd. -57.55 Million TWD 155.469%
Orient Pharma Co., Ltd. 633.6 Million TWD 94.961%
InnoPharmax Inc. -17.85 Million TWD 278.777%
Johnson Chemical Pharmaceutical Works Co., Ltd. -926.77 Million TWD 103.445%
Excelsior Biopharma Inc. -212.51 Million TWD 115.023%
DV Biomed Co., Ltd. 160.7 Million TWD 80.133%
Foresee Pharmaceuticals Co., Ltd. -781.42 Million TWD 104.086%
Handa Pharmaceuticals, Inc. -653.8 Million TWD 104.883%
UniPharma Co., Ltd. -68.36 Million TWD 146.698%
Anxo Pharmaceutical Co., Ltd. 492.4 Million TWD 93.516%
Alar Pharmaceuticals Inc. -738.05 Million TWD 104.326%
Winston Medical Supply Co., Ltd. -191.81 Million TWD 116.645%
Mercury Biopharmaceutical Corporation -1.94 Million TWD 1741.44%
Bioray Biotech Co., Ltd -27.23 Million TWD 217.237%
TSH Biopharm Corporation Limited -568.74 Million TWD 105.613%